Found: 6
Select item for more details and to access through your institution.
Developing the Totality of Evidence for Biosimilars: Regulatory Considerations and Building Confidence for the Healthcare Community.
- Published in:
- BioDrugs, 2017, v. 31, n. 3, p. 175, doi. 10.1007/s40259-017-0218-5
- By:
- Publication type:
- Article
NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
P-ERK Activation by Extracellular or Intracellular Acidosis Slows NHE3-Mediated Acid Extrusion And Activates Ammoniagenesis in LLC-PK1-F+ Cells.
- Published in:
- FASEB Journal, 2007, v. 21, n. 6, p. A1414, doi. 10.1096/fasebj.21.6.a1414-c
- By:
- Publication type:
- Article
Use of tumor necrosis factor-α (TNF-α) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients.
- Published in:
- Clinical Rheumatology, 2009, v. 28, n. 7, p. 787, doi. 10.1007/s10067-009-1149-4
- By:
- Publication type:
- Article
Histological evaluation of liver in two rheumatoid arthritis patients with chronic hepatitis B and C treated with TNF-alpha blockade: case reports.
- Published in:
- Clinical Rheumatology, 2008, v. 27, n. 8, p. 1069, doi. 10.1007/s10067-008-0896-y
- By:
- Publication type:
- Article